Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
Yahoo Finance · 1 week ago
Open | 275.27 |
High | 279.77 |
Low | 274.91 |
Mkt Cap | 7.89B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 275.60 |
52 Wk. Low | 261.59 |
52 Wk. High | 473.50 |
Related stocks
Bio Technology Firm
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 681.18M | 6.70% ▼ |
Net Income | 349.71M | 57.80% ▼ |
Diluted EPS | 3.10 | 56.30% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | $2.15 | - |
Q4 2023 | $2.82 | $3.10 |
Q3 2023 | $2.78 | $2.33 |
S&P 500^GSPC | 5,099.96+51.54 (+1.02%) |
Dow 30^DJI | 38,239.66+153.86 (+0.40%) |
Nasdaq^IXIC | 15,927.90+316.14 (+2.03%) |
Bitcoin USDBTC-USD | 63,562.18+1.43% |
Ethereum USDETH-USD | 3,266.51+5.58% |
Docebo Inc.DCBO | 44.72+1.64% |